Immedica wins accelerated approval for once-rejected rare disease drug
Article Title: Immedica wins accelerated approval for once-rejected rare disease drug Publication Date: February 24, 2026 The Swedish biotech firm Immedica recently received accelerated approval from the FDA, giving new life to a treatment that was previously rejected but now…